BAMF Health is a biotechnology company that designs, develops, and builds cyclotron-equipped radiopharmacies and clinics. It works with an aim to achieve an intelligence-based, personalized medicine through AI-enabled molecular imaging and theranostics. It produces novel tracers that are efficient, effective, and non-invasive diagnostics for cancer, Alzheimer’s, Parkinson’s, and cardiac disease as well as advanced applications for PTSD and depression. In 2018, Anthony Chang and Anderson Peck established it in Grand Rapids, Michigan.
